Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, 8032 Zurich, Switzerland,
Neuroscience Centre Zurich, University of Zurich, 8057 Zurich, Switzerland.
J Neurosci. 2019 Nov 20;39(47):9424-9434. doi: 10.1523/JNEUROSCI.1285-19.2019. Epub 2019 Oct 15.
Associative memory can be rendered malleable by a reminder. Blocking the ensuing reconsolidation process is suggested as a therapeutic target for unwanted aversive memories. Matrix metalloproteinase-9 (MMP-9) is required for structural synapse remodeling involved in memory consolidation. Inhibiting MMP-9 with doxycycline is suggested to attenuate human threat conditioning. Here, we investigated whether MMP-9 inhibition also interferes with threat memory reconsolidation. Male and female human participants ( = 78) learned the association between two visual conditioned stimuli (CS) and a 50% chance of an unconditioned nociceptive stimulus (US), and between CS and the absence of US. On day 7, one CS was reminded without reinforcement 3.5 h after ingesting either 200 mg of doxycycline or placebo. On day 14, retention of CS memory was assessed under extinction by fear-potentiated startle. Contrary to our expectations, we observed a greater CS/CS difference in participants who were reminded under doxycycline compared with placebo. Participants who were reminded under placebo showed extinction learning during the retention test, which was not observed in the doxycycline group. There was no difference between the reminded and the nonreminded CS in either group. In contrast, during relearning after the retention test, the CS/CS difference was more pronounced in the placebo group than in the doxycycline group. To summarize, a single dose of doxycycline before threat memory reminder appeared to have no specific impact on reconsolidation, but to globally impair extinction learning, and threat relearning, beyond drug clearance. Matrix metalloproteinase-9 inhibition appears to attenuate memory consolidation. It could also be a target for blocking reconsolidation. Here, we test this hypothesis in human threat conditioning. We find that doxycycline has no specific impact on a reminded cue, but confers a global reduction in extinction learning and threat learning beyond the clearance of the drug. This may point toward a more long-lasting impact of doxycycline treatment on memory plasticity.
关联记忆可以通过提示进行改变。阻止随后的再巩固过程被认为是治疗不良厌恶记忆的治疗靶点。基质金属蛋白酶-9(MMP-9)是参与记忆巩固的结构突触重塑所必需的。用强力霉素抑制 MMP-9 被认为可以减弱人类威胁条件作用。在这里,我们研究了 MMP-9 抑制是否也会干扰威胁记忆的再巩固。男性和女性人类参与者(= 78)学习了两个视觉条件刺激(CS)与 50%无条件伤害性刺激(US)之间的关联,以及 CS 与 US 不存在之间的关联。在第 7 天,在摄入 200 毫克强力霉素或安慰剂 3.5 小时后,没有强化地提醒一个 CS。在第 14 天,通过恐惧增强的惊跳来评估 CS 记忆在消退中的保留情况。与我们的预期相反,我们观察到在强力霉素组中,与安慰剂相比,在被提醒时 CS/CS 差异更大。在安慰剂组中,在保留测试期间观察到了消退学习,而在强力霉素组中则没有观察到。在提醒和未提醒的 CS 之间,两组都没有差异。相比之下,在保留测试后的重新学习期间,安慰剂组的 CS/CS 差异比强力霉素组更为明显。总之,在威胁记忆提醒之前单次给予强力霉素似乎对再巩固没有特定影响,但会在药物清除之外全局损害消退学习和威胁再学习。基质金属蛋白酶-9 抑制似乎可以减弱记忆巩固。它也可能是阻止再巩固的靶点。在这里,我们在人类威胁条件作用中测试了这一假设。我们发现,强力霉素对提醒线索没有特定影响,但在药物清除之外,会导致消退学习和威胁学习的全面减少。这可能表明强力霉素治疗对记忆可塑性的影响更为持久。